Nexstim H2 2022: Slight miss – but long term profitability in sight - Redeye
Redeye provides a research update after Nexstim's H2 report, which came in slightly below our projections. As a result, we have made minor adjustments to our base case and provided our perspective on 2023.
ANNONS
Redeye provides a research update after Nexstim's H2 report, which came in slightly below our projections. As a result, we have made minor adjustments to our base case and provided our perspective on 2023.